Stay updated on Asciminib Combo with Imatinib in CML-CP Clinical Trial

Sign up to get notified when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Asciminib Combo with Imatinib in CML-CP Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:59:29.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T23:10:15.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Deleted key study documents and IPD-sharing details from the Study Documents section (including the Statistical Analysis Plan and Study Protocol) along with related metadata and keywords. This removes ready access to primary methodological materials and data-sharing information on the study page.
    Difference
    21%
    Check dated 2026-09-22T23:19:29.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The website's revision identifier was updated to v3.7.0, reflecting a new build of the site. This appears to be an internal platform update rather than a change to study content or listings.
    Difference
    0.0%
    Check dated 2026-09-15T21:53:54.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the study page, indicating a routine update to the page’s revision metadata. This update does not modify the study content or results.
    Difference
    0.0%
    Check dated 2026-09-01T18:37:25.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    An NIH grant/contract identifier (2018) was added to the study's identifiers, updating the funding attribution. This change updates metadata rather than core trial design or results.
    Difference
    0.0%
    Check dated 2026-08-25T21:41:29.000Z thumbnail image

Stay in the know with updates to Asciminib Combo with Imatinib in CML-CP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.